April 5, 2018 (Neurology Today) A protein associated with glioblastoma multiform (GBM) has been identified and in experiments has proven to be a promising new target for immunotherapy against these …
At the Bench-Glioblastoma: Immunotherapy for Glioblastoma Has a New and Potentially Powerful Target Read More
April 27, 2018 (Medical News Today) T cells, a type of white blood cell, have an innate ability to recognize, attack and kill cancer cells. However, it is very apparent …
This ‘genetic switch’ could help to fight cancer Read More
June 4, 2018 (HealthDay News) Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients MONDAY, June 4, 2018 (HealthDay News) — A new immunotherapy appears …
Immunotherapy Promising for Slowing Progression of ALS Read More
May 19, 2018 (Medical News Today) This study was published in the Journal of Experimental Medicine. It discovered that when cholesterol levels are decreased, cancer fighting immunotherapy is more effective. …
New Study Finds that Lowering Cholesterol Improves Immunotherapy Read More
April 11, 2018 (HealthDay News) One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab Gemcitabine and cisplatin (GC) plus ipilimumab is associated with a 69 percent objective …
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer Read More
In January, ASCO published its 13th annual report in Clinical Cancer Advances 2018, and named chimeric antigen receptor (CAR) T-cell immunotherapy as its Advance of the Year. This repost highlights …
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO Read More
January 23, 2018 (Medical News Today) A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important part of the immune system that …
‘Cross-dressing’ cells may improve cancer treatment Read More
March 2, 2018 (Medical News Today) At present, the most common types of treatment for cancer – the leading cause of death – are chemotherapy, radiation, surgery, and hormonal therapy, …
The state of cancer: Are we close to a cure? Read More
November 28, 2017 (Discovery Medicine) Glioblastoma remains a major unmet medical need in the field of oncology. With less than 10% of patients surviving five years from initial diagnosis, it …
Immunotherapy for Glioblastoma: On the Sidelines or in the Game? Read More
March 23, 2018 (Medical News Today) A biodegradable gel has been developed to stop the recurrence of cancer. Scientists at the Dana-Farber Cancer Institute in Boston, MA, created a gel …
Cancer: How a novel gel could halt its return Read More